-+ 0.00%
-+ 0.00%
-+ 0.00%

AbCellera Biologics announces annual shareholder meeting notice

PUBT·04/29/2026 18:08:39
Listen to the news
AbCellera Biologics announces annual shareholder meeting notice
  • AbCellera Biologics schedules virtual annual shareholder meeting for June 11, 2026.
  • Shareholders will vote on election of two Class III directors, including John S. Montalbano and Stephen R. Quake.
  • Meeting agenda includes ratification of Ernst & Young as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Non-binding advisory vote on named executive officer compensation also set for shareholder consideration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001703057-26-000020), on April 29, 2026, and is solely responsible for the information contained therein.